OAR 836-200-0545: Public Disclosure of Prescription Drug Manufacturer Filings
Edition: Current OARD snapshotEffective: 2025-04-01Last verified: 2026-09-07
(1) As soon as practicable after receiving a filing from a prescription drug manufacturer under OAR 836-200-0530 to 836-200-0532, the department shall post to its website the name of the manufacturer and the prescription drug that is the subject of the filing. (2) Notwithstanding section (1), if a manufacturer has made a trade secret claim, the information that is the subject of the trade secret claim will not be posted to the department's website until a determination has been made by the department or, in the case of a manufacturer's appeal, the director, as specified by OAR 836-200-0540. (3) No information determined by the department or the director to be exempt from disclosure under OAR 836-200-0540 shall be included in the information posted to the department's website.
Official history and status
Statutory/Other Authority: ORS 646A.689
Statutes/Other Implemented: ORS 646A.689
History: ID 2-2025, amend filed 03/26/2025, effective 04/01/2025 ID 1-2020, amend filed 01/29/2020, effective 02/01/2020 ID 2-2019, adopt filed 02/26/2019, effective 03/01/2019
This rule cites
- OAR 836-200-0530 — resolved
- 836-200-0532 — resolved
- OAR 836-200-0540 — resolved
Cited by
Official source: https://secure.sos.state.or.us/oard/